(Q47761298)

http://europepmc.org/abstract/MED/28951085

5 February 2018

title

Cost-effectiveness of a potential group B streptococcal vaccine for pregnant women in the United States (English)

1 reference

http://europepmc.org/abstract/MED/28951085

5 February 2018

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28951085%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

6

Stephanie J Schrag

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28951085%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

author name string

Sun-Young Kim

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28951085%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Chi Nguyen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28951085%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Louise B Russell

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28951085%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Fatimah Abdul-Hakeem

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28951085%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Jennifer R Verani

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28951085%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Anushua Sinha

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28951085%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

language of work or name

English

0 references

publication date

23 September 2017

1 reference

http://europepmc.org/abstract/MED/28951085

5 February 2018

published in

Vaccine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28951085%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28951085%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

issue

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28951085%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

page(s)

6238-6247

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28951085%20AND%20SRC:MED&resulttype=core&format=json

ACOG Committee Opinion No. 485: Prevention of early-onset group B streptococcal disease in newborns

31 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.085

Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.085

Maternal Immunization With an Investigational Trivalent Group B Streptococcal Vaccine: A Randomized Controlled Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.085

A randomized, observer-blind Phase Ib study to identify formulations and vaccine schedules of a trivalent Group B Streptococcus vaccine for use in non-pregnant and pregnant women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.085

Revisiting the Need for Vaccine Prevention of Late-Onset Neonatal Group B Streptococcal Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.085

Epidemiology of Invasive Group B Streptococcal Disease in the United States, 1999-2005

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.085

Prevention of group B streptococcal disease in the first 3 months of life: would routine maternal immunization during pregnancy be cost-effective?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.085

Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.085

Twenty Years of Active Bacterial Core Surveillance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.085

Assessment of intrapartum antibiotic prophylaxis for the prevention of early-onset group B Streptococcal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.085

Effectiveness of intrapartum antibiotic prophylaxis for prevention of early-onset group B streptococcal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.085

Acceptability of a hypothetical group B strep vaccine among pregnant and recently delivered women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.085

Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.085

Antibiotic use and misuse during pregnancy and delivery: benefits and risks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.085

Introduction of the new Centers for Disease Control and Prevention group B streptococcal prevention guideline at a large West Coast health maintenance organization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.085

Long-term sequelae of childhood bacterial meningitis: an underappreciated problem

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.085

Long-term neurodevelopmental outcomes after intrauterine and neonatal insults: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.085

The EQ-5D and the Health Utilities Index for permanent sequelae after meningitis: a head-to-head comparison.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.085

Thresholds for the cost-effectiveness of interventions: alternative approaches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.085

Preventive strategies for group B streptococcal and other bacterial infections in early infancy: cost effectiveness and value of information analyses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.085

The projected health benefits of maternal group B streptococcal vaccination in the era of chemoprophylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.085

Group B streptococcus and early-onset sepsis in the era of maternal prophylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.085

Long-term outcomes of group B streptococcal meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.085

Early hospital discharge of infants born to group B streptococci-positive mothers: a decision analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.085

10.1016/J.VACCINE.2017.08.085

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28951085%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

1 reference